NDC 72208-588 - The Ordinary Sulfur 10% Powder-to-Cream Concentrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72208-588
- Package NDCs from labels
- 72208-588-01
- Manufacturer
- Deciem
- Effective date
- 2025-11-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| The Ordinary Sulfur 10% Powder-to-Cream Concentrate - Deciem | Deciem | 2025-11-13 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM Eczema | CALENDULA, ECHINACEA, GRAPHITE, SULFUR | BM Private Limited | 388ceb70-1de2-df89-e063-6294a90a3896 | 2026-02-12 | Warnings | 70FD1KFU70 |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Sodium Sulfacetamide and Sulfur | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals, LLC | d35a7764-f3c6-fd1b-e053-2a95a90a8036 | 2026-02-12 | Warnings | 70FD1KFU70 |
| Sodium Sulfacetamide 9% and Sulfur 4% Cleanser | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals | d770b9e2-dbbe-c246-e053-2995a90a398d | 2026-02-12 | Warnings, Adverse reactions | 70FD1KFU70 |
| Sodium Sulfacetamide 9% and Sulfur 4.5% Cleanser | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals | d770860b-ecbd-ba22-e053-2a95a90af691 | 2026-02-12 | Warnings, Adverse reactions | 70FD1KFU70 |
| Sodium Sulfacetamide 8% and Sulfur 4% Cleanser | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals | d8dcbf63-58f0-0a25-e053-2a95a90a7633 | 2026-02-12 | Warnings, Adverse reactions | 70FD1KFU70 |
| Sodium Sulfacetamide 10% and Sulfur 2% Cleanser | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals | d736fbd6-4cff-bc33-e053-2a95a90a26fd | 2026-02-12 | Warnings, Adverse reactions | 70FD1KFU70 |
| SODIUM SULFACETAMIDE 10% AND SULFUR 5% Emollient Cream | SODIUM SULFACETAMIDE 10% AND SULFUR 5% EMOLLIENT CREAM | Method Pharmaceuticals, LLC | dfc5bab2-2170-606e-e053-2a95a90a3961 | 2026-02-12 | Warnings, Adverse reactions | 70FD1KFU70 |
| sulfacetamide sodium and sulfur Sodium Sulfacetamide - Sulfur | SULFACETAMIDE SODIUM AND SULFUR | Allegis Pharmaceuticals, LLC | 1aa1025f-c568-34d3-e063-6394a90a37b8 | 2026-02-11 | Warnings, Adverse reactions | 70FD1KFU70 |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| dermveda NAIL FUNGUS SERUM | OLIVE EXTRACT, SULFUR | Celcius Corp. | 6d999dac-7b84-4f19-957e-5c787a4e96c4 | 2026-02-09 | Warnings | 70FD1KFU70 |
| Dermveda JOCK ITCH | SULPHUR, CURCUMA LONGA | Celcius Corp. | bb9c3941-a778-49ba-b58c-75ab5b93b3d0 | 2026-02-09 | Warnings | 70FD1KFU70 |
| dermveda PSORIASIS AND SEBORRHEIC DERMATITIS | SULFUR, CURCUMA LONGA | Celcius Corp. | a05c1e45-ca2f-49a1-a3f9-32dc51278fb6 | 2026-02-09 | Warnings | 70FD1KFU70 |
| dermveda SCABIES ITCH RELIEF SERUM | OLIVE EXTRACT, SULFUR | Celcius Corp. | 86a8bffd-81a8-4f22-89b6-e51158f336db | 2026-02-09 | Warnings | 70FD1KFU70 |
| dermveda JOCK ITCH | OLIVE EXTRACT, SULFUR | Celcius Corp. | 252ed439-0e4c-419f-8b34-d1b52da8464f | 2026-02-06 | Warnings | 70FD1KFU70 |
| Cough and Mucus Night | ANTIMONIUM TARTARICUM, AVENA SATIVA, BRYONIA (ALBA), CHAMOMILLA, DROSERA (ROTUNDIFOLIA), HEPAR SULPHURIS CALCAREUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, PASSIFLORA INCARNATA, PULSATILLA (PRATENSIS), SAMBUCUS NIGRA, STANNUM METALLICUM, SULPHUR | NaturalCare | f27e3a7f-78a3-4003-95fc-0b32671df443 | 2026-02-02 | Warnings | 70FD1KFU70 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.